Behavioral changes in male mice fed a high-fat diet are associated with IL-1β expression in specific brain regions

Physiology and Behavior

Volumn 169, Issue , 2017, Pages 130-140

  Almeida Suhett, Camila P ^a   Graham, Alice ^a   Chen, Yifan ^a   Deuster, Patricia ^a  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

Amygdala; Anxiety like behavior; Cognitive deficit; High fat diet; Hippocampus; Interleukin 1

Indexed keywords

INTERLEUKIN 1BETA; LEPTIN RECEPTOR; ACTIN BINDING PROTEIN; AIF1 PROTEIN, MOUSE; CALCIUM BINDING PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN;

AMYGDALA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; BEHAVIOR CHANGE; BRAIN REGION; COGNITION; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; DIET THERAPY; ELEVATED ZERO MAZE TEST; FORCED SWIM TEST; FRONTAL CORTEX; GENE EXPRESSION; GENETIC ASSOCIATION; HIPPOCAMPUS; IMAGE ANALYSIS; IMMUNOREACTIVITY; LIPID DIET; MALE; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; WEIGHT GAIN; WORKING MEMORY; Y-MAZE TEST; ADVERSE EFFECTS; ANIMAL; ANIMAL BEHAVIOR; BODY WEIGHT; BRAIN; C57BL MOUSE; COGNITION DISORDERS; DISEASE MODEL; EXPLORATORY BEHAVIOR; GENE EXPRESSION REGULATION; GENETICS; GLUCOSE TOLERANCE TEST; MAZE TEST; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; SWIMMING;

ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; BRAIN; CALCIUM-BINDING PROTEINS; COGNITION DISORDERS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE TOLERANCE TEST; INTERLEUKIN-1BETA; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICROFILAMENT PROTEINS; SWIMMING;

EID: 85002194804     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2016.11.016     Document Type: Article

References (94)

1. [1] Vadiveloo, M., Scott, M., Quatromoni, P., Jacques, P., Parekh, N., Trends in dietary fat and high-fat food intakes from 1991 to 2008 in the Framingham heart study participants. Br. J. Nutr. 111 (2014), 724–734.
2. [2] WHO, Obesity and overweight. http://www.who.int/mediacentre/factsheets/fs311/en/, 2015.
3. [3] Elias, M.F., Elias, P.K., Sullivan, L.M., Wolf, P.A., D'Agostino, R.B., Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int. J. Obes. Relat. Metab. Disord. 27 (2003), 260–268.
4. [4] Elias, M.F., Elias, P.K., Sullivan, L.M., Wolf, P.A., D'Agostino, R.B., Obesity, diabetes and cognitive deficit: the Framingham heart study. Neurobiol. Aging 26:Suppl. 1 (2005), 11–16.
5. [5] Cournot, M., Marquie, J.C., Ansiau, D., Martinaud, C., Fonds, H., Ferrieres, J., et al. Relation between body mass index and cognitive function in healthy middle-aged men and women. Neurology 67 (2006), 1208–1214.
6. [6] Sabia, S., Nabi, H., Kivimaki, M., Shipley, M.J., Marmot, M.G., Singh-Manoux, A., Health behaviors from early to late midlife as predictors of cognitive function: the Whitehall II study. Am. J. Epidemiol. 170 (2009), 428–437.
7. [7] West, N.A., Haan, M.N., Body adiposity in late life and risk of dementia or cognitive impairment in a longitudinal community-based study. J. Gerontol. A Biol. Sci. Med. Sci. 64 (2009), 103–109.
8. [8] Kerwin, D.R., Gaussoin, S.A., Chlebowski, R.T., Kuller, L.H., Vitolins, M., Coker, L.H., et al. Interaction between body mass index and central adiposity and risk of incident cognitive impairment and dementia: results from the women's health initiative memory study. J. Am. Geriatr. Soc. 59 (2011), 107–112.
9. [9] Simon, G.E., Von Korff, M., Saunders, K., Miglioretti, D.L., Crane, P.K., van Belle, G., et al. Association between obesity and psychiatric disorders in the US adult population. Arch. Gen. Psychiatry 63 (2006), 824–830.
10. [10] Scott, K.M., Bruffaerts, R., Simon, G.E., Alonso, J., Angermeyer, M., de Girolamo, G., et al. Obesity and mental disorders in the general population: results from the world mental health surveys. Int. J. Obes. 32 (2008), 192–200.
11. [11] Gariepy, G., Nitka, D., Schmitz, N., The association between obesity and anxiety disorders in the population: a systematic review and meta-analysis. Int. J. Obes. 34 (2010), 407–419.
12. [12] Lykouras, L., Michopoulos, J., Anxiety disorders and obesity. Psychiatriki 22 (2011), 307–313.
13. [13] Gariepy, G., Wang, J., Lesage, A.D., Schmitz, N., The longitudinal association from obesity to depression: results from the 12-year National Population Health Survey. Obesity (Silver Spring) 18 (2010), 1033–1038.
14. [14] Onyike, C.U., Crum, R.M., Lee, H.B., Lyketsos, C.G., Eaton, W.W., Is obesity associated with major depression? Results from the Third National Health and Nutrition Examination Survey. Am. J. Epidemiol. 158 (2003), 1139–1147.
15. [15] Dong, C., Sanchez, L.E., Price, R.A., Relationship of obesity to depression: a family-based study. Int. J. Obes. Relat. Metab. Disord. 28 (2004), 790–795.
16. [16] Stunkard, A.J., Faith, M.S., Allison, K.C., Depression and obesity. Biol. Psychiatry 54 (2003), 330–337.
17. [17] Winzell, M.S., Ahren, B., The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 53:Suppl. 3 (2004), S215–S219.
18. [18] Buettner, R., Scholmerich, J., Bollheimer, L.C., High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring) 15 (2007), 798–808.
19. [19] Gallou-Kabani, C., Vige, A., Gross, M.S., Rabes, J.P., Boileau, C., Larue-Achagiotis, C., et al. C57BL/6J and A/J mice fed a high-fat diet delineate components of metabolic syndrome. Obesity (Silver Spring) 15 (2007), 1996–2005.
20. [20] Fraulob, J.C., Ogg-Diamantino, R., Fernandes-Santos, C., Aguila, M.B., Mandarim-de-Lacerda, C.A., A mouse model of metabolic syndrome: insulin resistance, fatty liver and non-alcoholic fatty pancreas disease (NAFPD) in C57BL/6 mice fed a high fat diet. J. Clin. Biochem. Nutr. 46 (2010), 212–223.
21. [21] Cordner, Z.A., Tamashiro, K.L., Effects of high-fat diet exposure on learning & memory. Physiol. Behav. 152 (2015), 363–371.
22. [22] Sharma, S., Fulton, S., Diet-induced obesity promotes depressive-like behaviour that is associated with neural adaptations in brain reward circuitry. Int. J. Obes. 37 (2013), 382–389.
23. [23] Kurhe, Y., Mahesh, R., Gupta, D., Effect of a selective cyclooxygenase type 2 inhibitor celecoxib on depression associated with obesity in mice: an approach using behavioral tests. Neurochem. Res. 39 (2014), 1395–1402.
24. [24] Kurhe, Y., Radhakrishnan, M., Gupta, D., Ondansetron attenuates depression co-morbid with obesity in obese mice subjected to chronic unpredictable mild stress; an approach using behavioral battery tests. Metab. Brain Dis. 29 (2014), 701–710.
25. [25] Kurhe, Y., Mahesh, R., Ondansetron attenuates co-morbid depression and anxiety associated with obesity by inhibiting the biochemical alterations and improving serotonergic neurotransmission. Pharmacol. Biochem. Behav. 136 (2015), 107–116.
26. [26] Zemdegs, J., Quesseveur, G., Jarriault, D., Penicaud, L., Fioramonti, X., Guiard, B.P., High fat diet-induced metabolic disorders impairs serotonergic function and anxiety-like behaviours in mice. Br. J. Pharmacol., 2015.
27. [27] Kang, S.S., Jeraldo, P.R., Kurti, A., Miller, M.E., Cook, M.D., Whitlock, K., et al. Diet and exercise orthogonally alter the gut microbiome and reveal independent associations with anxiety and cognition. Mol. Neurodegener., 9, 2014, 36.
28. [28] Sivanathan, S., Thavartnam, K., Arif, S., Elegino, T., McGowan, P.O., Chronic high fat feeding increases anxiety-like behaviour and reduces transcript abundance of glucocorticoid signalling genes in the hippocampus of female rats. Behav. Brain Res. 286 (2015), 265–270.
29. [29] Andre, C., Dinel, A.L., Ferreira, G., Laye, S., Castanon, N., Diet-induced obesity progressively alters cognition, anxiety-like behavior and lipopolysaccharide-induced depressive-like behavior: focus on brain indoleamine 2,3-dioxygenase activation. Brain Behav. Immun. 41 (2014), 10–21.
30. [30] Li, W., Prakash, R., Chawla, D., Du, W., Didion, S.P., Filosa, J.A., et al. Early effects of high-fat diet on neurovascular function and focal ischemic brain injury. Am. J. Phys. Regul. Integr. Comp. Phys. 304 (2013), R1001–R1008.
31. [31] Lynch, C.M., Kinzenbaw, D.A., Chen, X., Zhan, S., Mezzetti, E., Filosa, J., et al. Nox2-derived superoxide contributes to cerebral vascular dysfunction in diet-induced obesity. Stroke 44 (2013), 3195–3201.
32. [32] Freeman, L.R., Haley-Zitlin, V., Stevens, C., Granholm, A.C., Diet-induced effects on neuronal and glial elements in the middle-aged rat hippocampus. Nutr. Neurosci. 14 (2011), 32–44.
33. [33] Knight, E.M., Martins, I.V., Gumusgoz, S., Allan, S.M., Lawrence, C.B., High-fat diet-induced memory impairment in triple-transgenic Alzheimer's disease (3xTgAD) mice is independent of changes in amyloid and tau pathology. Neurobiol. Aging 35 (2014), 1821–1832.
34. [34] Boitard, C., Cavaroc, A., Sauvant, J., Aubert, A., Castanon, N., Laye, S., et al. Impairment of hippocampal-dependent memory induced by juvenile high-fat diet intake is associated with enhanced hippocampal inflammation in rats. Brain Behav. Immun. 40 (2014), 9–17.
35. [35] Sobesky, J.L., Barrientos, R.M., De May, H.S., Thompson, B.M., Weber, M.D., Watkins, L.R., et al. High-fat diet consumption disrupts memory and primes elevations in hippocampal IL-1beta, an effect that can be prevented with dietary reversal or IL-1 receptor antagonism. Brain Behav. Immun. 42 (2014), 22–32.
36. [36] Miller, A.A., Spencer, S.J., Obesity and neuroinflammation: a pathway to cognitive impairment. Brain Behav. Immun. 42 (2014), 10–21.
37. [37] Molteni, R., Barnard, R.J., Ying, Z., Roberts, C.K., Gomez-Pinilla, F., A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning. Neuroscience 112 (2002), 803–814.
38. [38] Stranahan, A.M., Norman, E.D., Lee, K., Cutler, R.G., Telljohann, R.S., Egan, J.M., et al. Diet-induced insulin resistance impairs hippocampal synaptic plasticity and cognition in middle-aged rats. Hippocampus 18 (2008), 1085–1088.
39. [39] Lindqvist, A., Mohapel, P., Bouter, B., Frielingsdorf, H., Pizzo, D., Brundin, P., et al. High-fat diet impairs hippocampal neurogenesis in male rats. Eur. J. Neurol. 13 (2006), 1385–1388.
40. [40] Park, H.R., Park, M., Choi, J., Park, K.Y., Chung, H.Y., Lee, J., A high-fat diet impairs neurogenesis: involvement of lipid peroxidation and brain-derived neurotrophic factor. Neurosci. Lett. 482 (2010), 235–239.
41. [41] Davis, M., Rainnie, D., Cassell, M., Neurotransmission in the rat amygdala related to fear and anxiety. Trends Neurosci. 17 (1994), 208–214.
42. [42] Kim, M.J., Loucks, R.A., Palmer, A.L., Brown, A.C., Solomon, K.M., Marchante, A.N., et al. The structural and functional connectivity of the amygdala: from normal emotion to pathological anxiety. Behav. Brain Res. 223 (2011), 403–410.
43. [43] LeDoux, J., The emotional brain, fear, and the amygdala. Cell. Mol. Neurobiol. 23 (2003), 727–738.
44. [44] Holzschneider, K., Mulert, C., Neuroimaging in anxiety disorders. Dialogues Clin. Neurosci. 13 (2011), 453–461.
45. [45] Chiu, G.S., Darmody, P.T., Walsh, J.P., Moon, M.L., Kwakwa, K.A., Bray, J.K., et al. Adenosine through the A2A adenosine receptor increases IL-1beta in the brain contributing to anxiety. Brain Behav. Immun. 41 (2014), 218–231.
46. [46] Engler, H., Doenlen, R., Engler, A., Riether, C., Prager, G., Niemi, M.B., et al. Acute amygdaloid response to systemic inflammation. Brain Behav. Immun. 25 (2011), 1384–1392.
47. [47] Koo, J.W., Duman, R.S., Interleukin-1 receptor null mutant mice show decreased anxiety-like behavior and enhanced fear memory. Neurosci. Lett. 456 (2009), 39–43.
48. [48] Konsman, J.P., Veeneman, J., Combe, C., Poole, S., Luheshi, G.N., Dantzer, R., Central nervous action of interleukin-1 mediates activation of limbic structures and behavioural depression in response to peripheral administration of bacterial lipopolysaccharide. Eur. J. Neurosci. 28 (2008), 2499–2510.
49. [49] Connor, K.M., Davidson, J.R., Generalized anxiety disorder: neurobiological and pharmacotherapeutic perspectives. Biol. Psychiatry 44 (1998), 1286–1294.
50. [50] Oh, H., Boghossian, S., York, D.A., Park-York, M., The effect of high fat diet and saturated fatty acids on insulin signaling in the amygdala and hypothalamus of rats. Brain Res. 1537 (2013), 191–200.
51. [51] Areias, M.F., Prada, P.O., Mechanisms of insulin resistance in the amygdala: influences on food intake. Behav. Brain Res. 282 (2015), 209–217.
52. [52] Boitard, C., Maroun, M., Tantot, F., Cavaroc, A., Sauvant, J., Marchand, A., et al. Juvenile obesity enhances emotional memory and amygdala plasticity through glucocorticoids. J. Neurosci. 35 (2015), 4092–4103.
53. [53] Castro, G., MF, C.A., Weissmann, L., Quaresma, P.G., Katashima, C.K., Saad, M.J., et al. Diet-induced obesity induces endoplasmic reticulum stress and insulin resistance in the amygdala of rats. FEBS Open Bio 3 (2013), 443–449.
54. [54] Erion, J.R., Wosiski-Kuhn, M., Dey, A., Hao, S., Davis, C.L., Pollock, N.K., et al. Obesity elicits interleukin 1-mediated deficits in hippocampal synaptic plasticity. J. Neurosci. 34 (2014), 2618–2631.
55. [55] Belzung, C., Griebel, G., Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav. Brain Res. 125 (2001), 141–149.
56. [56] Prut, L., Belzung, C., The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur. J. Pharmacol. 463 (2003), 3–33.
57. [57] Shepherd, J.K., Grewal, S.S., Fletcher, A., Bill, D.J., Dourish, C.T., Behavioural and pharmacological characterisation of the elevated “zero-maze” as an animal model of anxiety. Psychopharmacology 116 (1994), 56–64.
58. [58] Lalonde, R., The neurobiological basis of spontaneous alternation. Neurosci. Biobehav. Rev. 26 (2002), 91–104.
59. [59] Biggan, S.L., Beninger, R.J., Cockhill, J., Jhamandas, K., Boegman, R.J., Quisqualate lesions of rat NBM: selective effects on working memory in a double Y-maze. Brain Res. Bull. 26 (1991), 613–616.
60. [60] Porsolt, R.D., Bertin, A., Jalfre, M., Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 229 (1977), 327–336.
61. [61] Porsolt, R.D., Bertin, A., Jalfre, M., “Behavioural despair” in rats and mice: strain differences and the effects of imipramine. Eur. J. Pharmacol. 51 (1978), 291–294.
62. [62] Petit-Demouliere, B., Chenu, F., Bourin, M., Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology 177 (2005), 245–255.
63. [63] Islam, A., Abraham, P., Hapner, C.D., Andrews-Shigaki, B., Deuster, P., Chen, Y., Heat exposure induces tissue stress in heat-intolerant, but not heat-tolerant, mice. Stress 16 (2013), 244–253.
64. [64] Chiu, K., Lau, W.M., Lau, H.T., So, K.F., Chang, R.C., Micro-dissection of rat brain for RNA or protein extraction from specific brain region. J. Vis. Exp., 2007, 269.
65. [65] Hernandez-Plata, E., Ortiz, C.S., Marquina-Castillo, B., Medina-Martinez, I., Alfaro, A., Berumen, J., et al. Overexpression of NaV 1.6 channels is associated with the invasion capacity of human cervical cancer. Int. J. Cancer (Trans.) Journal international du cancer, 130, 2012, 2013–2023.
66. [66] Casola, C., Schiwek, J.E., Reinehr, S., Kuehn, S., Grus, F.H., Kramer, M., et al. S100 alone has the same destructive effect on retinal ganglion cells as in combination with HSP 27 in an autoimmune glaucoma model. J. Mol. Neurosci. 56 (2015), 228–236.
67. [67] Almeida-Suhett, C.P., Prager, E.M., Pidoplichko, V., Figueiredo, T.H., Marini, A.M., Li, Z., et al. Reduced GABAergic inhibitory transmission in the BLA and the development of anxiety-like behaviors after mTBI. PLoS One, 9(7), 2014, e102627.
68. [68] Pandya, M., Altinay, M., Malone, D.A. Jr., Anand, A., Where in the brain is depression?. Curr. Psychiatry Rep. 14 (2012), 634–642.
69. [69] Almeida-Suhett, C.P., Prager, E.M., Pidoplichko, V., Figueiredo, T.H., Marini, A.M., Li, Z., et al. GABAergic interneuronal loss and reduced inhibitory synaptic transmission in the hippocampal CA1 region after mild traumatic brain injury. Exp. Neurol. 273 (2015), 11–23.
70. [70] Lu, J., Wu, D.M., Zheng, Y.L., Hu, B., Cheng, W., Zhang, Z.F., et al. Ursolic acid improves high fat diet-induced cognitive impairments by blocking endoplasmic reticulum stress and IkappaB kinase beta/nuclear factor-kappaB-mediated inflammatory pathways in mice. Brain Behav. Immun. 25 (2011), 1658–1667.
71. [71] Jeon, B.T., Jeong, E.A., Shin, H.J., Lee, Y., Lee, D.H., Kim, H.J., et al. Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet. Diabetes 61 (2012), 1444–1454.
72. [72] Xia, S.F., Xie, Z.X., Qiao, Y., Li, L.R., Cheng, X.R., Tang, X., et al. Differential effects of quercetin on hippocampus-dependent learning and memory in mice fed with different diets related with oxidative stress. Physiol. Behav. 138 (2015), 325–331.
73. [73] Kishi, T., Hirooka, Y., Nagayama, T., Isegawa, K., Katsuki, M., Takesue, K., et al. Calorie restriction improves cognitive decline via up-regulation of brain-derived neurotrophic factor: tropomyosin-related kinase B in hippocampus of obesity-induced hypertensive rats. Int. Heart J. 56 (2015), 110–115.
74. [74] Kaczmarczyk, M.M., Machaj, A.S., Chiu, G.S., Lawson, M.A., Gainey, S.J., York, J.M., et al. Methylphenidate prevents high-fat diet (HFD)-induced learning/memory impairment in juvenile mice. Psychoneuroendocrinology 38 (2013), 1553–1564.
75. [75] Kosari, S., Badoer, E., Nguyen, J.C., Killcross, A.S., Jenkins, T.A., Effect of western and high fat diets on memory and cholinergic measures in the rat. Behav. Brain Res. 235 (2012), 98–103.
76. [76] Lavin, D.N., Joesting, J.J., Chiu, G.S., Moon, M.L., Meng, J., Dilger, R.N., et al. Fasting induces an anti-inflammatory effect on the neuroimmune system which a high-fat diet prevents. Obesity (Silver Spring) 19 (2011), 1586–1594.
77. [77] Dinel, A.L., Andre, C., Aubert, A., Ferreira, G., Laye, S., Castanon, N., Cognitive and emotional alterations are related to hippocampal inflammation in a mouse model of metabolic syndrome. PLoS One, 6, 2011, e24325.
78. [78] Wan, C.S., Chiou, W.B., The motivations of adolescents who are addicted to online games: a cognitive perspective. Adolescence 42 (2007), 179–197.
79. [79] Carson, M.J., Thrash, J.C., Walter, B., The cellular response in neuroinflammation: the role of leukocytes, microglia and astrocytes in neuronal death and survival. Clin. Neurosci. Res. 6 (2006), 237–245.
80. [80] Norden, D.M., Trojanowski, P.J., Villanueva, E., Navarro, E., Godbout, J.P., Sequential activation of microglia and astrocyte cytokine expression precedes increased Iba-1 or GFAP immunoreactivity following systemic immune challenge. Glia 64 (2016), 300–316.
81. [81] Ejike, C.E., Body shape dissatisfaction is a 'normative discontent' in a young-adult Nigerian population: a study of prevalence and effects on health-related quality of life. J. Epidemiol. Glob. Health 5:4 Suppl 1 (2015), S19–S26.
82. [82] Grundy, A., Cotterchio, M., Kirsh, V.A., Kreiger, N., Associations between anxiety, depression, antidepressant medication, obesity and weight gain among Canadian women. PLoS One, 9, 2014, e99780.
83. [83] Hasler, G., Pine, D.S., Gamma, A., Milos, G., Ajdacic, V., Eich, D., et al. The associations between psychopathology and being overweight: a 20-year prospective study. Psychol. Med. 34 (2004), 1047–1057.
84. [84] Finger, B.C., Dinan, T.G., Cryan, J.F., Leptin-deficient mice retain normal appetitive spatial learning yet exhibit marked increases in anxiety-related behaviours. Psychopharmacology 210 (2010), 559–568.
85. [85] Asakawa, A., Inui, A., Inui, T., Katsuura, G., Fujino, M.A., Kasuga, M., Leptin treatment ameliorates anxiety in ob/ob obese mice. J. Diabetes Complicat. 17 (2003), 105–107.
86. [86] Tchelingerian, J.L., Quinonero, J., Booss, J., Jacque, C., Localization of TNF alpha and IL-1 alpha immunoreactivities in striatal neurons after surgical injury to the hippocampus. Neuron 10 (1993), 213–224.
87. [87] de Bock, F., Dornand, J., Rondouin, G., Release of TNF alpha in the rat hippocampus following epileptic seizures and excitotoxic neuronal damage. Neuroreport 7 (1996), 1125–1129.
88. [88] Almeida-Suhett, C.P., Li, Z., Marini, A.M., Braga, M.F., Eiden, L.E., Temporal course of changes in gene expression suggests a cytokine-related mechanism for long-term hippocampal alteration after controlled cortical impact. J. Neurotrauma 31 (2014), 683–690.
89. [89] Vitkovic, L., Konsman, J.P., Bockaert, J., Dantzer, R., Homburger, V., Jacque, C., Cytokine signals propagate through the brain. Mol. Psychiatry 5 (2000), 604–615.
90. [90] Porsolt, R.D., Le Pichon, M., Jalfre, M., Depression: a new animal model sensitive to antidepressant treatments. Nature 266 (1977), 730–732.
91. [91] Cryan, J.F., Holmes, A., The ascent of mouse: advances in modelling human depression and anxiety. Nat. Rev. Drug Discov. 4 (2005), 775–790.
92. [92] Yamada, N., Katsuura, G., Ochi, Y., Ebihara, K., Kusakabe, T., Hosoda, K., et al. Impaired CNS leptin action is implicated in depression associated with obesity. Endocrinology 152 (2011), 2634–2643.
93. [93] Clegg, D.J., Gotoh, K., Kemp, C., Wortman, M.D., Benoit, S.C., Brown, L.M., et al. Consumption of a high-fat diet induces central insulin resistance independent of adiposity. Physiol. Behav. 103 (2011), 10–16.
94. [94] Waise, T.M., Toshinai, K., Naznin, F., NamKoong, C., Md Moin, A.S., Sakoda, H., et al. One-day high-fat diet induces inflammation in the nodose ganglion and hypothalamus of mice. Biochem. Biophys. Res. Commun. 464 (2015), 1157–1162.